KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of GoodwillAmortization of GoodwillAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ginkgo Bioworks Holdings (DNA) Cash from Operations (2020 - 2025)

Ginkgo Bioworks Holdings filings provide 6 years of Cash from Operations readings, the most recent being 47678000.0 for Q4 2025.

  • On a quarterly basis, Cash from Operations fell 12.36% to 47678000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was 171059000.0, a 46.47% increase, with the full-year FY2025 number at 171059000.0, up 46.47% from a year prior.
  • Cash from Operations hit 47678000.0 in Q4 2025 for Ginkgo Bioworks Holdings, down from 31606000.0 in the prior quarter.
  • In the past five years, Cash from Operations ranged from a high of 5235000.0 in Q3 2021 to a low of 165541000.0 in Q4 2021.
  • Median Cash from Operations over the past 5 years was 54676000.0 (2023), compared with a mean of 64608000.0.
  • Biggest five-year swings in Cash from Operations: crashed 441.76% in 2022 and later skyrocketed 69.46% in 2025.
  • Ginkgo Bioworks Holdings' Cash from Operations stood at 165541000.0 in 2021, then skyrocketed by 36.85% to 104531000.0 in 2022, then surged by 44.68% to 57831000.0 in 2023, then rose by 26.62% to 42435000.0 in 2024, then decreased by 12.36% to 47678000.0 in 2025.
  • The last three reported values for Cash from Operations were 47678000.0 (Q4 2025), 31606000.0 (Q3 2025), and 40254000.0 (Q2 2025) per Business Quant data.